PROMMIS trial prospectively demonstrates the efficacy of SKY92 risk stratification in newly diagnosed multiple myeloma patients Meeting Abstract
| Authors: | Biran, N.; Dhakal, B.; Niesvizky, R.; Lentzsch, S.; McKay, J. T.; Vesole, D. H.; Nooka, A. K.; Paul, B.; Hari, P. N.; Stork-Sloots, L.; D'Ambrosi, S.; Kuiper, R.; van Vliet, M.; Siegel, D. S.; Usmani, S. Z.; van Rhee, F. |
| Abstract Title: | PROMMIS trial prospectively demonstrates the efficacy of SKY92 risk stratification in newly diagnosed multiple myeloma patients |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 3386 |
| Language: | English |
| ACCESSION: | WOS:001159740303249 |
| DOI: | 10.1182/blood-2023-180761 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
